Toll Free: 1-888-928-9744

Global and China Oral Antihyperglycemic Drugs Research Report to 2020

Published: Jun 22, 2016 | Pages: 141 | Publisher: QYResearch | Industry: Medical Devices | Report Format: Electronic (PDF)

The diabetes market is estimated to reach over $60 billion a year. And Oral Antihyperglycemic Drugs share over 60% of the market, and is expected to grow at the GARE of 10%.
This report studies Oral Antihyperglycemic Drugs in Global and China market, focuses on top manufacturers in global and China market, involving Oral Antihyperglycemic Drugs price of each type, sales, revenue and market share for each manufacturers. This report also displays the sales, revenue and market share of Oral Antihyperglycemic Drugs in USA, EU, China, Japan, India and Southeast Asia, forecast to 2020, from 2011. 

Split by product types, with sales, revenue, market share and price of each type, as well as the types and price of each type price for each manufacturer in 2015 and 2016, through interviewing the key manufacturers, covering 
Sensitizers
Secretagogues
Alpha-glucosidase inhibitors
DPP-4 inhibitors

Split by manufacturers, this report focuses on the sales, price of each type, average price of Oral Antihyperglycemic Drugs, revenue and market share, for each manufacturer in 2015 and 2016. Top players, covering 
Eli Lilly
AstraZeneca
Bayer
Takeda
GSK
Novo nordisk
Novartis
Pfizer
Sinofi
Boehringer-Ingelheim
SERVIER
Merck
Alphapharm
HANSOH PHARMA
HUADONG MEDICINE
LUYE PHARMA
HENGRUI PHARMACEUTICAL
TIPR Pharmaceutical
PKU HEALTHCARE
Jiangsu Heng Rui Medicine

Split by regions, this report focuses on the sales (consumption), revenue and market share of Oral Antihyperglycemic Drugs in these regions, from 2011 to 2020 (forecast), covering 
USA
EU
Japan
China
India 
Southeast Asia

 Table of Content
Global and China Oral Antihyperglycemic Drugs Research Report to 2020 1 Oral Antihyperglycemic Drugs Overview and Price of Each Type 1.1 Product Overview and Scope of Oral Antihyperglycemic Drugs 1.2 Global and China Oral Antihyperglycemic Drugs Sales, Growth Rate 2011 to 2020 1.3 Global and China Oral Antihyperglycemic Drugs Revenue, Growth Rate 2011 to 2020 1.4 Product Segments and Price of Each Type 1.4.1 Sensitizers and Price List (2015-2016) 1.4.1.1 Biguanides 1.4.1.2 Thiazolidinediones 1.4.2 Secretagogues and Price List (2015-2016) 1.4.2.1 Sulfonylureas 1.4.2.2 Nonsulfonylurea secretagogues 1.4.3 Alpha-glucosidase inhibitors and Price List (2015-2016) 1.4.4 DPP-4 inhibitors and Price List (2015-2016) 1.5 Price List (Interviewed) of Each Type for Key Manufacturers in 2015 and 2016 1.5.1 Price List (Interviewed) of Sensitizers by Key Manufacturers 1.5.2 Price List (Interviewed) of Secretagogues by Key Manufacturers 1.5.3 Price List (Interviewed) of Alpha-glucosidase inhibitors by Key Manufacturers 1.5.4 Price List (Interviewed) of DPP-4 inhibitors by Key Manufacturers 1.6 Global and China Oral Antihyperglycemic Drugs Market Share by Type in 2015 1.6.1 Global Oral Antihyperglycemic Drugs Market Share by Type in 2015 1.6.2 China Oral Antihyperglycemic Drugs Market Share by Type in 2015 2 Global and China Market Competition Analysis by Manufacturers 2.1 Global Market Oral Antihyperglycemic Drugs Sales, Revenue and Share List of Key Manufacturers 2015 to 2016 2.1.1 Global Market Oral Antihyperglycemic Drugs Sales and Share of Key Manufacturers 2015 to 2016 2.1.2 Global Market Oral Antihyperglycemic Drugs Revenue and Share of Key Manufacturers 2015 to 2016 2.1.3 Global Market Oral Antihyperglycemic Drugs Average Price of Key Manufacturers 2015 to 2016 2.2 China Market Oral Antihyperglycemic Drugs Sales, Revenue and Share of Key Manufacturers 2015 to 2016 2.2.1 China Market Oral Antihyperglycemic Drugs Sales and Share of Key Manufacturers 2015 to 2016 2.2.2 China Market Oral Antihyperglycemic Drugs Revenue and Share of Key Manufacturers 2015 to 2016 2.3 Global Oral Antihyperglycemic Drugs Manufacturing Base Distribution and Product Type of each Manufacturer 3 Global and China Oral Antihyperglycemic Drugs Sales, Revenue and Growth Rate by Type 3.1 Global Oral Antihyperglycemic Drugs Sales, Revenue and Growth Rate by Type (2011-2020) 3.1.1 Global Oral Antihyperglycemic Drugs Sales and Market Share by Type (2011-2020) 3.1.2 Global Oral Antihyperglycemic Drugs Revenue and Market Share by Type (2011-2020) 3.1.3 Global Oral Antihyperglycemic Drugs Price by Type (2011-2020) 3.2 Global Oral Antihyperglycemic Drugs Sales Growth Rate by Type (2011-2020) 3.2.1 Sensitizers Sales and Sales Growth Rate 2011-2020 3.2.2 Secretagogues Sales and Sales Growth Rate 2011-2020 3.2.3 Alpha-glucosidase inhibitors Sales and Sales Growth Rate 2011-2020 3.2.4 DPP-4 inhibitors Sales and Sales Growth Rate 2011-2020 3.3 China Oral Antihyperglycemic Drugs Sales, Revenue and Growth Rate by Type (2011-2020) 3.3.1 China Oral Antihyperglycemic Drugs Sales and Market Share by Type (2011-2020) 3.3.4 China Oral Antihyperglycemic Drugs Revenue and Market Share by Type (2011-2020) 3.3.3 China Oral Antihyperglycemic Drugs Price by Type (2011-2020) 3.4 China Oral Antihyperglycemic Drugs Sales Growth Rate by Type (2011-2020) 3.4.1 Sensitizers Sales and Sales Growth Rate 2011-2020 3.4.2 Secretagogues Sales and Sales Growth Rate 2011-2020 3.4.3 Alpha-glucosidase inhibitors Sales and Sales Growth Rate 2011-2020 3.4.4 DPP-4 inhibitors Sales and Sales Growth Rate 2011-2020 4 Global and China Oral Antihyperglycemic Drugs Key Manufacturers Analysis 4.1 Eli Lilly 4.1.1 Company Basic Information, Manufacturing Base and Competitors 4.1.2 Oral Antihyperglycemic Drugs Product Segment of Eli Lilly 4.1.2.1 Jardiance and Price in 2015 and 2016 of Eli Lilly 4.1.2.2 Jentadueto and Price in 2015 and 2016 of Eli Lilly 4.1.2.3 Synjardy and Price in 2015 and 2016 of Eli Lilly 4.1.2.4 Tradjenta and Price in 2015 and 2016 of Eli Lilly 4.1.2.5 Trulicity and Price in 2015 and 2016 of Eli Lilly 4.1.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Eli Lilly 2015 to 2016 4.1.4 Interviewee, Name and Contact 4.2 AstraZeneca 4.2.1 Company Basic Information, Manufacturing Base and Competitors 4.2.2 Oral Antihyperglycemic Drugs Product Segment of AstraZeneca 4.2.2.1 Bydureon and Price in 2015 and 2016 of AstraZeneca 4.2.2.2 Byetta and Price in 2015 and 2016 of AstraZeneca 4.2.2.3 Kombiglyze XR and Price in 2015 and 2016 of AstraZeneca 4.2.2.4 Komboglyze and Price in 2015 and 2016 of AstraZeneca 4.2.2.5 Onglyza and Price in 2015 and 2016 of AstraZeneca 4.2.2.6 Symlin and Price in 2015 and 2016 of AstraZeneca 4.2.2.7 XIGDUO XR and Price in 2015 and 2016 of AstraZeneca 4.2.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of AstraZeneca 2015 to 2016 4.2.4 Interviewee, Name and Contact 4.3 Bayer 4.3.1 Company Basic Information, Manufacturing Base and Competitors 4.3.2 Oral Antihyperglycemic Drugs Product Segment of Bayer 4.3.2.1 Glucobay and Price in 2015 and 2016 of Bayer 4.3.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Bayer 2015 to 2016 4.3.4 Interviewee, Name and Contact 4.4 Takeda 4.4.1 Company Basic Information, Manufacturing Base and Competitors 4.4.2 Oral Antihyperglycemic Drugs Product Segment of Takeda by Type 4.4.2.1 ACTOS and Price in 2015 and 2016 of Takeda 4.4.2.2 ACTOPLUS MET and Price in 2015 and 2016 of Takeda 4.4.2.3 ACTOPLUS MET XR and Price in 2015 and 2016 of Takeda 4.4.2.4 DUETACT and Price in 2015 and 2016 of Takeda 4.4.2.5 OSENI and Price in 2015 and 2016 of Takeda 4.4.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Takeda 2015 to 2016 4.4.4 Interviewee, Name and Contact 4.5 GSK 4.5.1 Company Basic Information, Manufacturing Base and Competitors 4.5.2 Oral Antihyperglycemic Drugs Product Segment of GSK 4.5.2.1 Avandia and Price in 2015 and 2016 of GSK 4.5.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of GSK 2015 to 2016 4.5.4 Interviewee, Name and Contact 4.6 Novo Nordisk 4.6.1 Company Basic Information, Manufacturing Base and Competitors 4.6.2 Oral Antihyperglycemic Drugs Product Segment of Novo nordisk by 4.6.2.1 Novonorm and Price in 2015 and 2016 of Novo nordisk 4.6.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Novo nordisk 2015 to 2016 4.6.4 Interviewee, Name and Contact 4.7 Novartis 4.7.1 Company Basic Information, Manufacturing Base and Competitors 4.7.2 Oral Antihyperglycemic Drugs Product Segment of Novartis 4.7.2.1 Starlix and Price in 2015 and 2016 of Novartis 4.7.2.2 Galvus and Price in 2015 and 2016 of Novartis 4.7.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Novartis 2015 to 2016 4.7.4 Interviewee, Name and Contact 4.8 Pfizer 4.8.1 Company Basic Information, Manufacturing Base and Competitors 4.8.2 Oral Antihyperglycemic Drugs Product Segment of Pfizer by Type 4.8.2.1 Glucotrol XL and Price in 2015 and 2016 of Pfizer 4.8.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Pfizer 2015 to 2016 4.8.4 Interviewee, Name and Contact 4.9 Sinofi 4.9.1 Company Basic Information, Manufacturing Base and Competitors 4.9.2 Oral Antihyperglycemic Drugs Product Segment of Sinofi 4.9.2.1 Sensitizers and Price in 2015 and 2016 of Sinofi 4.9.2.2 Secretagogues and Price in 2015 and 2016 of Sinofi 4.9.2.3 Alpha-glucosidase inhibitors and Price in 2015 and 2016 of Sinofi 4.9.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Sinofi 2015 to 2016 4.9.4 Interviewee, Name and Contact 4.10 Boehringer-Ingelheim 4.10.1 Company Basic Information, Manufacturing Base and Competitors 4.10.2 Oral Antihyperglycemic Drugs Product Segment of Boehringer-Ingelheim 4.10.2.1 Tradjenta and Price in 2015 and 2016 of Boehringer-Ingelheim 4.10.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Boehringer-Ingelheim 2015 to 2016 4.10.4 Interviewee, Name and Contact 4.11 SERVIER 4.11.1 Company Basic Information, Manufacturing Base and Competitors 4.11.2 Oral Antihyperglycemic Drugs Product Segment of SERVIER 4.11.2.1 Diamicron and Price in 2015 and 2016 of SERVIER 4.11.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of SERVIER 2015 to 2016 4.11.4 Interviewee, Name and Contact 4.12 Merck 4.12.1 Company Basic Information, Manufacturing Base and Competitors 4.12.2 Oral Antihyperglycemic Drugs Product Segment of Merck 4.12.2.1 Janumet and Price in 2015 and 2016 of Merck 4.12.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Merck 2015 to 2016 4.12.4 Interviewee, Name and Contact 4.13 Alphapharm 4.13.1 Company Basic Information, Manufacturing Base and Competitors 4.13.2 Oral Antihyperglycemic Drugs Product Segment of Alphapharm 4.13.2.1 Diaformin and Price in 2015 and 2016 of Alphapharm 4.13.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Alphapharm 2015 to 2016 4.13.4 Interviewee, Name and Contact 4.14 HANSOH PHARMA 4.14.1 Company Basic Information, Manufacturing Base and Competitors 4.14.2 Oral Antihyperglycemic Drugs Product Segment of HANSOH PHARMA 4.14.2.1 Fulaiyin and Price in 2015 and 2016 of HANSOH PHARMA 4.14.2.2 Fulaihe and Price in 2015 and 2016 of HANSOH PHARMA 4.14.2.3 Fulaidi and Price in 2015 and 2016 of HANSOH PHARMA 4.14.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of HANSOH PHARMA 2015 to 2016 4.14.4 Interviewee, Name and Contact 4.15 HUADONG MEDICINE 4.15.1 Company Basic Information, Manufacturing Base and Competitors 4.15.2 Oral Antihyperglycemic Drugs Product Segment of HUADONG MEDICINE 4.15.2.1 Kaboping and Price in 2015 and 2016 of HUADONG MEDICINE 4.15.2.2 Kashuangping and Price in 2015 and 2016 of HUADONG MEDICINE 4.15.2.3 Kafuping and Price in 2015 and 2016 of HUADONG MEDICINE 4.15.2.4 Kasiping and Price in 2015 and 2016 of HUADONG MEDICINE 4.15.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of HUADONG MEDICINE 2015 to 2016 4.15.4 Interviewee, Name and Contact 4.16 LUYE PHARMA 4.16.1 Company Basic Information, Manufacturing Base and Competitors 4.16.2 Oral Antihyperglycemic Drugs Product Segment of LUYE PHARMA 4.16.2.1 Beikangning and Price in 2015 and 2016 of LUYE PHARMA 4.16.2.2 Beixi and Price in 2015 and 2016 of LUYE PHARMA 4.16.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of LUYE PHARMA 2015 to 2016 4.16.4 Interviewee, Name and Contact 4.17 HENGRUI PHARMACEUTICAL 4.17.1 Company Basic Information, Manufacturing Base and Competitors 4.17.2 Oral Antihyperglycemic Drugs Product Segment of HENGRUI PHARMACEUTICAL 4.17.2.1 Aineng and Price in 2015 and 2016 of HENGRUI PHARMACEUTICAL 4.17.2.2 Xianfudi and Price in 2015 and 2016 of HENGRUI PHARMACEUTICAL 4.17.2.3 Beishun and Price in 2015 and 2016 of HENGRUI PHARMACEUTICAL 4.17.2.4 Shuangneng and Price in 2015 and 2016 of HENGRUI PHARMACEUTICAL 4.17.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of HENGRUI PHARMACEUTICAL 2015 to 2016 4.17.4 Interviewee, Name and Contact 4.18 TIPR Pharmaceutical 4.18.1 Company Basic Information, Manufacturing Base and Competitors 4.18.2 Oral Antihyperglycemic Drugs Product Segment of TIPR Pharmaceutical 4.18.2.1 Jieshi and Price in 2015 and 2016 of TIPR Pharmaceutical 4.18.2.2 Jiebei and Price in 2015 and 2016 of TIPR Pharmaceutical 4.18.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of TIPR Pharmaceutical 2015 to 2016 4.18.4 Interviewee, Name and Contact 4.19 PKU HEALTHCARE 4.19.1 Company Basic Information, Manufacturing Base and Competitors 4.19.2 Oral Antihyperglycemic Drugs Product Segment of TIPR Pharmaceutical 4.19.2.1 Kedeping and Price in 2015 and 2016 of TIPR Pharmaceutical 4.19.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of TIPR Pharmaceutical 2015 to 2016 4.19.4 Interviewee, Name and Contact 4.20 Jiangsu Heng Rui Medicine 4.20.1 Company Basic Information, Manufacturing Base and Competitors 4.20.2 Oral Antihyperglycemic Drugs Product Segment of Jiangsu Heng Rui Medicine 4.20.2.1 Kedeping and Price in 2015 and 2016 of Jiangsu Heng Rui Medicine 4.20.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Jiangsu Heng Rui Medicine 2015 to 2016 4.20.4 Interviewee, Name and Contact 5 Global Oral Antihyperglycemic Drugs Analysis by Regions 2011-2020 5.1 Global Oral Antihyperglycemic Drugs Sales and Revenue by Regions 2011-2020 5.1.1 Global Oral Antihyperglycemic Drugs Sales by Regions 2011-2020 5.1.2 Global Oral Antihyperglycemic Drugs Revenue by Regions 2011-2020 5.2 USA Oral Antihyperglycemic Drugs Sales and Revenue Growth Rate 2011-2020 5.3 EU Oral Antihyperglycemic Drugs Sales and Revenue Growth Rate 2011-2020 5.4 Japan Oral Antihyperglycemic Drugs Sales and Revenue Growth Rate 2011-2020 5.5 Southeast Asia Oral Antihyperglycemic Drugs Sales and Revenue Growth Rate 2011-2020 5.6 India Oral Antihyperglycemic Drugs Sales and Revenue Growth Rate 2011-2020 6 Oral Antihyperglycemic Drugs Research Progress and Development Trend 6.1 Oral Antihyperglycemic Drugs Research Progress Analysis 6.1.1 Global Oral Antihyperglycemic Drugs Research Progress 6.1.2 China Oral Antihyperglycemic Drugs Research Progress 6.2 Oral Antihyperglycemic Drugs Research Development Trend Analysis 6.2.1 Global Oral Antihyperglycemic Drugs Research Development Trend 6.2.2 China Oral Antihyperglycemic Drugs Research Development Trend 7 Policies and News Analysis for Oral Antihyperglycemic Drugs 7.1 Global Policies Analysis for Oral Antihyperglycemic Drugs 7.2 Global News Analysis for Oral Antihyperglycemic Drugs 7.3 China Policies Analysis for Oral Antihyperglycemic Drugs 7.4 China News Analysis for Oral Antihyperglycemic Drugs 7 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Oral Antihyperglycemic Drugs Figure Global Oral Antihyperglycemic Drugs Sales and Growth Rate 2011 to 2020 Figure China Oral Antihyperglycemic Drugs Sales and Growth Rate 2011 to 2020 Figure Global Oral Antihyperglycemic Drugs Revenue and Growth Rate 2011 to 2020 Figure China Oral Antihyperglycemic Drugs Revenue and Growth Rate 2011 to 2020 Figure Picture of Biguanides Figure Picture of Thiazolidinediones Figure Picture of Sulfonylureas Figure Picture of Nonsulfonylurea secretagogues Figure Picture of Alpha-glucosidase inhibitors Figure Picture of DPP-4 inhibitors Table Price List (Interviewed) of Type 1 by Key Manufacturers in 2015 and 2016 Table Price List (Interviewed) of Secretagogues by Key Manufacturers in 2015 and 2016 Table Price List (Interviewed) of Alpha-glucosidase inhibitors by Key Manufacturers in 2015 and 2016 Table Price List (Interviewed) of DPP-4 inhibitors by Key Manufacturers in 2015 and 2016 Figure Global Oral Antihyperglycemic Drugs Market Share by Type in 2015 Figure China Oral Antihyperglycemic Drugs Market Share by Type in 2015 Table Global Market Oral Antihyperglycemic Drugs Sales of Key Manufacturers 2015 to 2016 Table Global Market Oral Antihyperglycemic Drugs Sales Share of Key Manufacturers 2015 to 2016 Table Global Market Oral Antihyperglycemic Drugs Revenue of Key Manufacturers 2015 to 2016 Table Global Market Oral Antihyperglycemic Drugs Revenue Share of Key Manufacturers 2015 to 2016 Table Global Market Oral Antihyperglycemic Drugs Average Price of Key Manufacturers 2015 to 2016 Table China Market Oral Antihyperglycemic Drugs Sales of Key Manufacturers 2015 to 2016 Table China Market Oral Antihyperglycemic Drugs Sales Share of Key Manufacturers 2015 to 2016 Table China Market Oral Antihyperglycemic Drugs Revenue of Key Manufacturers 2015 to 2016 Table China Market Oral Antihyperglycemic Drugs Revenue Share of Key Manufacturers 2015 to 2016 Table Global Oral Antihyperglycemic Drugs Manufacturing Base Distribution and Product Type of each Manufacturer Table Global Oral Antihyperglycemic Drugs Sales by Type (2011-2020) Table Global Oral Antihyperglycemic Drugs Sales Market Share by Type (2011-2020) Table Global Oral Antihyperglycemic Drugs Revenue by Type (2011-2020) Table Global Oral Antihyperglycemic Drugs Revenue Market Share by Type (2011-2020) Figure Global Oral Antihyperglycemic Drugs Price by Type (2011-2020) Figure Sensitizers Sales and Sales Growth Rate 2011-2020 Figure Secretagogues Sales and Sales Growth Rate 2011-2020 Figure Alpha-glucosidase inhibitors Sales and Sales Growth Rate 2011-2020 Figure DPP-4 inhibitors Sales and Sales Growth Rate 2011-2020 Table China Oral Antihyperglycemic Drugs Sales by Type (2011-2020) Table China Oral Antihyperglycemic Drugs Sales Market Share by Type (2011-2020) Table China Oral Antihyperglycemic Drugs Revenue by Type (2011-2020) Table China Oral Antihyperglycemic Drugs Revenue Market Share by Type (2011-2020) Figure China Oral Antihyperglycemic Drugs Price by Type (2011-2020) Figure Sensitizers Sales and Sales Growth Rate 2011-2020 Figure Secretagogues Sales and Sales Growth Rate 2011-2020 Figure Alpha-glucosidase inhibitors Sales and Sales Growth Rate 2011-2020 Figure DPP-4 inhibitors Sales and Sales Growth Rate 2011-2020 Table Eli Lilly Basic Information List Table Jardiance and Price in 2015 and 2016 of Eli Lilly Table Jentadueto and Price in 2015 and 2016 of Eli Lilly Table Synjardy and Price in 2015 and 2016 of Eli Lilly Table Jentadueto and Price in 2015 and 2016 of Eli Lilly Table Synjardy and Price in 2015 and 2016 of Eli Lilly Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of Eli Lilly 2015 to 2016 Table AstraZeneca Basic Information List Table Bydureon and Price in 2015 and 2016 of AstraZeneca Table Byetta and Price in 2015 and 2016 of AstraZeneca Table Kombiglyze XR and Price in 2015 and 2016 of AstraZeneca Table Kombiglyze and Price in 2015 and 2016 of AstraZeneca Table Onglyza and Price in 2015 and 2016 of AstraZeneca Table Symlin and Price in 2015 and 2016 of AstraZeneca Table XIGDUO XR and Price in 2015 and 2016 of AstraZeneca Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of AstraZeneca 2015 to 2016 Table Bayer Basic Information List Table Glucobay and Price in 2015 and 2016 of Bayer Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of Bayer 2015 to 2016 Table Takeda Basic Information List Table ACTOS and Price in 2015 and 2016 of Takeda Table ACTOPLUS MET and Price in 2015 and 2016 of Takeda Table ACTOPLUS MET XR and Price in 2015 and 2016 of Takeda Table ACTOPLUS MET XR and Price in 2015 and 2016 of Takeda Table ACTOPLUS MET XR and Price in 2015 and 2016 of Takeda Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of Takeda 2015 to 2016 Table GSK Basic Information List Table Sensitizers and Price in 2015 and 2016 of GSK Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of GSK 2015 to 2016 Table Novo nordisk Basic Information List Table Novonorm and Price in 2015 and 2016 of Novo nordisk Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of Novo nordisk 2015 to 2016 Table Novartis Basic Information List Table Starlix and Price in 2015 and 2016 of Novartis Table Galvus and Price in 2015 and 2016 of Novartis Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of Novartis 2015 to 2016 Table Pfizer Basic Information List Table Glucotrol XL and Price in 2015 and 2016 of Pfizer Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of Pfizer 2015 to 2016 Table Sinofi Basic Information List Table Sensitizers and Price in 2015 and 2016 of Sinofi Table Secretagogues and Price in 2015 and 2016 of Sinofi Table Alpha-glucosidase inhibitors and Price in 2015 and 2016 of Sinofi Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of Sinofi 2015 to 2016 Table Boehringer-Ingelheim Basic Information List Table Tradjenta and Price in 2015 and 2016 of Boehringer-Ingelheim Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of Boehringer-Ingelheim 2015 to 2016 Table SERVIER Basic Information List Table Diamicron and Price in 2015 and 2016 of SERVIER Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of SERVIER 2015 to 2016 Table Merck Basic Information List Table Janumet and Price in 2015 and 2016 of Merck Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of Merck 2015 to 2016 Table Alphapharm Basic Information List Table Diamicron and Price in 2015 and 2016 of Alphapharm Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of Alphapharm 2015 to 2016 Table HANSOH PHARMA Basic Information List Table Fulaiyin and Price in 2015 and 2016 of HANSOH PHARMA Table Fulaihe and Price in 2015 and 2016 of HANSOH PHARMA Table Fulaidi and Price in 2015 and 2016 of HANSOH PHARMA Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of HANSOH PHARMA 2015 to 2016 Table HUADONG MEDICINE Basic Information List Table Kaboping and Price in 2015 and 2016 of HUADONG MEDICINE Table Kashuangping and Price in 2015 and 2016 of HUADONG MEDICINE Table Kafuping and Price in 2015 and 2016 of HUADONG MEDICINE Table Kasiping and Price in 2015 and 2016 of HUADONG MEDICINE Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of HUADONG MEDICINE 2015 to 2016 Table LUYE PHARMA Basic Information List Table Beikangning and Price in 2015 and 2016 of HUADONG MEDICINE Table Beixi and Price in 2015 and 2016 of LUYE PHARMA Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of HUADONG MEDICINE 2015 to 2016 Table HENGRUI PHARMACEUTICAL Basic Information List Table Aineng and Price in 2015 and 2016 of HENGRUI PHARMACEUTICAL Table Xianfudi and Price in 2015 and 2016 of HENGRUI PHARMACEUTICAL Table Beishun and Price in 2015 and 2016 of HENGRUI PHARMACEUTICAL Table Shuangneng and Price in 2015 and 2016 of HENGRUI PHARMACEUTICAL Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of HENGRUI PHARMACEUTICAL 2015 to 2016 Table TIPR Pharmaceutical Basic Information List Table Jieshi and Price in 2015 and 2016 of TIPR Pharmaceutical Table Jiebei and Price in 2015 and 2016 of TIPR Pharmaceutical Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of TIPR Pharmaceutical 2015 to 2016 Table TIPR Pharmaceutical Basic Information List Table Kedeping and Price in 2015 and 2016 of TIPR Pharmaceutical Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of TIPR Pharmaceutical 2015 to 2016 Table Jiangsu Heng Rui Medicine Basic Information List Table Kedeping and Price in 2015 and 2016 of Jiangsu Heng Rui Medicine Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of Jiangsu Heng Rui Medicine 2015 to 2016 Table Global Oral Antihyperglycemic Drugs Sales by Regions 2011-2020 Table Global Oral Antihyperglycemic Drugs Sales Share by Regions 2011-2020 Table Global Oral Antihyperglycemic Drugs Revenue by Regions 2011-2020 Table Global Oral Antihyperglycemic Drugs Revenue Share by Regions 2011-2020 Figure USA Oral Antihyperglycemic Drugs Sales Growth Rate 2011-2020 Figure USA Oral Antihyperglycemic Drugs Revenue Growth Rate 2011-2020 Figure EU Oral Antihyperglycemic Drugs Sales Growth Rate 2011-2020 Figure EU Oral Antihyperglycemic Drugs Revenue Growth Rate 2011-2020 Figure Japan Oral Antihyperglycemic Drugs Sales Growth Rate 2011-2020 Figure Japan Oral Antihyperglycemic Drugs Revenue Growth Rate 2011-2020 Figure Southeast Asia Oral Antihyperglycemic Drugs Sales Growth Rate 2011-2020 Figure Southeast Asia Oral Antihyperglycemic Drugs Revenue Growth Rate 2011-2020 Figure India Oral Antihyperglycemic Drugs Sales Growth Rate 2011-2020 Figure India Oral Antihyperglycemic Drugs Revenue Growth Rate 2011-2020



To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global automotive collision repair market is expected to be valued at USD 196.97 billion by 2020, as per a new research report by Radiant Insights, Inc. The industry is expected to witness significant growth owing to increasing number of on-road vehi

Read More...

Global Biocides market size is likely to be valued at USD 11.9 billion by 2022; as per a new research report by Radiant Insights, Inc. Growth in water treatment process units particularly in China, Japan and India is likely to drive demand. Increasin

Read More...

Global activated carbon market size is likely to be valued at USD 5.3 billion by 2020; as per a new research report by Radiant Insights, Inc. Increase in commercial & residential waste water treatment demand owing to escalation in water prices is ant

Read More...

Global fluorotelomers market size is anticipated to be valued at USD 539.3 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing application scope in fire fighting systems owing to growing safety concerns is likely to dri

Read More...

Global FPGA market is anticipated to be valued at USD 9,882.5 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing demand for customized IC’s is expected to drive the demand. Customized IC’s helps manufacturers to mo

Read More...
Choose License Type
Single User - US $2650
Multi User - US $5300
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify